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Abstract
Background: Self-medication with antibiotics is an important factor contributing to the development of bacterial
antibiotic resistance. The purpose of this study was to evaluate the prevalence of self-medication with antibiotics
for the treatment of menstrual symptoms among university women in Southwest Nigeria.
Methods: A cross-sectional survey was administered to female undergraduate and graduate students (n = 706) at
four universities in Southwest Nigeria in 2008. The universities were selected by convenience and the study
samples within each university were randomly selected cluster samples. The survey was self-administered and
included questions pertaining to menstrual symptoms, analgesic and antibiotic use patterns, and demographics.
Data were analyzed using descriptive statistics and logistic regression.
Results: The response rate was 95.4%. Eighty-six percent (95% CI: 83-88%) of participants experienced menstrual
symptoms, and 39% (95% CI: 36-43%) reported using analgesics to treat them. Overall, 24% (95% CI: 21-27%) of
participants reported self-medicated use of antibiotics to treat the following menstrual symptoms: cramps, bloating,
heavy bleeding, headaches, pimples/acne, moodiness, tender breasts, backache, joint and muscle pain. Factors
associated with this usage were: lower levels of education (Odds Ratio (OR): 2.8, 95% CI: 1.1-7.1, p-value: 0.03); non-
science major (OR: 1.58, 95% CI: 1.03-2.50, p-value: 0.04); usage of analgesics (OR: 3.17, 95% CI: 2.07-4.86, p-value:
<0.001); and mild to extreme heavy bleeding (OR: 1.64, 95% CI: 1.01-2.67, p-value: 0.05) and pimples/acne (OR: 1.57,
95% CI: 0.98-2.54, p-value: 0.06). Ampicillin, tetracycline, ciprofloxacin and metronidazole were used to treat the
most symptoms. Doctors or nurses (6%, 95% CI: 4-7%), friends (6%, 95% CI: 4-7%) and family members (7%, 95% CI:
5-8%) were most likely to recommend the use of antibiotics for menstrual symptoms, while these drugs were most
often obtained from local chemists or pharmacists (10.2%, 95% CI: 8-12%).
Conclusions: This is the first formal study to report that approximately 1 out of 4 university women surveyed in
Southwest Nigeria self-medicate with antibiotics to treat menstrual symptoms. This practice could provide monthly,
low-dose exposures to antibiotics among users. Further studies are necessary to evaluate the impacts of self-
medication on student health.
Background
Increasing rates of antimicrobial resistance have left clini-
cians with limited drug options for the treatment of bac-
terial infectious diseases. This is a major public health
concern worldwide, especially in developing countries
where higher rates of resistant bacterial infections persist
[1,2]. For example, rates of multiple antibiotic resistance
among urinary tract infection (UTI) bacterial isolates in
Southwest Nigeria are significantly higher than that of
any other country [3]. In addition, rates of other life-
threatening bacterial infections, such as community-
acquired methicillin-resistant Staphylococcus aureus
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(MRSA), continue to rise in African countries including
Nigeria [4] and Botswana [5]. Because the misuse and
abuse of antibiotics is a major cause of antimicrobial
resistance, research is needed to evaluate the specific
antibiotic usage patterns that are prevalent in develop-
ing countries so that interventions can be developed
and implemented. For such interventions to be effective,
we must also understand the underlying socio-cultural
factors that contribute to antimicrobial misuse and the
subsequent amplification of resistance in human popu-
lations [1,2].
In Nigeria, there are limited controls on the sale or
advertisement of antimicrobials, creating opportunities
for misinformation and misperceptions that can exacer-
bate improper antibiotic use [1,6]. In addition, counter-
feit drugs and poor pharmaceutical qualities of available
antimicrobials (containing no or substandard active
ingredients) have been widely reported [7-9]. These fac-
tors often lead to higher rates of resistance to less-
expensive first-line regimens compelling subsequent
changes in treatment protocols to include more expen-
sive and sometimes more toxic drugs [10]. In addition,
access to good and effective medical interventions is
often limited due to poor hospital facilities; service fees;
poverty and hunger; and illiteracy [1,2,6,11]. Patronage
of “quacks,” untrained individuals providing unconven-
tional and unhygienic medical care, is therefore wide-
spread and frequently becomes institutionalized as
normal.
Within this paradigm, self-medication–previously
defined by The World Health Organization [12]–is
widely encouraged, even among educated elites, as a jus-
tification for preserving the scarce resources of trained
physicians and other medical personnel [13]. Recent stu-
dies have sought to understand patterns of self-medica-
tion with antibiotics in developing and other countries
[13-17]. These studies have identified several indications
for self-medication with antibiotics including the com-
mon cold, [13,14,16] diarrhea or constipation,[15] and
sore throat [16]. In a pilot survey that we conducted in
July 2007 in Ago-Iwoye, Lagos, and Ibadan, Nigeria, we
observed a disturbing new trend among university
women of self-medication with antibiotics to treat men-
strual symptoms [6]. In particular, participating women
reported using antibiotics to reduce cramps, regulate
heavy flow and prevent “infections” from feminine sani-
tary products [6]. However, comprehensive data regard-
ing the magnitude of antibiotic self-medication for
menstrual symptoms, the specific “other” menstrual
symptoms that were being “treated,” and the characteris-
tics of the women who were more likely to self-medicate
were not collected.
Therefore, the purpose of the present study was to
determine the prevalence of self-medication with
antibiotics for the treatment of menstrual symptoms
among university women in Southwest Nigeria and to
evaluate factors associated with this practice. Our pilot
study [6] and a recent study conducted by Afolabi in
Lagos State, Nigeria [18], informed the selection of fac-
tors evaluated in the present study.
Methods
Survey Setting
This study was carried out in February 2008 at four uni-
versities (two public and two private universities) located
in Southwest Nigeria. The public universities were the
University of Ibadan (>12,000 total students) located in
Oyo State and Obafemi Awolowo University (25,000
total students) located in Osun State. The private uni-
versities were Covenant University (6,000 total students)
and Babcock University (6,000 total students), which are
both located in Ogun State. These universities were
selected via convenience sampling and were included in
the study because students attending public versus pri-
vate universities often represent different socioeconomic
groups and we sought to evaluate whether socioeco-
nomic status is one potential factor that influences the
use of antibiotics for menstrual symptoms among uni-
versity women.
The four universities included in the study account for
12% of the 34 operational universities in Southwest
Nigeria which are comprised of 6 federally-funded uni-
versities, 10 state-funded universities, and 18 privately-
owned universities [19]. These 34 universities represent
33% of the total 104 Nigerian universities which are
comprised of 27 federally-funded universities, 36 state-
funded universities and 41 privately-owned universities
throughout the country [20].
Approximately 69% of Nigerians complete primary
school [21], and a World Bank report published in 2000
estimated that higher education in Nigeria only enrolls
about 4% of the eligible age cohort [22]. A recent report
described that the proportion of female students attend-
ing Nigerian higher institutions is rising to about 47% of
overall students [19]. The proportion of female students
at the universities included in this study was approxi-
mately 50%.
Sample size calculation
A sample size calculation was performed using the fol-
lowing equation: n = (Z2 P(1-P))/(d2), where n = sample
size, Z = Z statistic corresponding to a chosen level of
confidence, P = expected prevalence, and d = precision
[23]. In our calculation, we used Z = 1.96, P = 0.3 and
d = 0.05. This calculation resulted in a sample size of
323. This sample size was doubled to account for the
clustered nature of the study design [24,25], resulting in
a sample size of 646. To account for non-responses,
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researchers typically increase the calculated sample size
by anywhere from 5 to 20% [24,25]. We increased the
sample size by 5% to account for non-responses, result-
ing in a sample size of 679. However, to be more con-
servative, we cushioned our sample size by an additional
(arbitrary) ~10%, arriving at a total sample size, n = 740.
This total sample size was divided by the number of
clusters (4 universities) included in the study to deter-
mine how many surveys should be administered at each
university [25,26]. This method of dividing the sample
equally among clusters was in accordance with “generic
cluster sample” design methods previously described by
the WHO Department of Vaccines and Biologicals [26].
Sampling strategy
At the University of Ibadan, Covenant University and
Obafemi Awolowo University, study participants were
recruited from residence halls. The sampling strategy at
these universities was a three-stage cluster sampling
plan. Female residence halls that housed both under-
graduate and graduate students were randomly selected
for inclusion in the study. Within the residence halls,
blocks of rooms were then randomly selected for inclu-
sion in the study and every resident of those rooms was
invited to participate in the survey.
At Babcock University, study participants were
recruited from lecture halls because we were ultimately
not granted access to the residence halls at this univer-
sity. Thus, at Babcock University, a one-stage cluster
sampling strategy was employed. Lecture halls that
housed both undergraduate and graduate classes were
randomly selected for participation in the study and
every female student within the randomly selected lec-
ture halls was invited to participate in the study.
Institutional review board (IRB) approval was granted
by the University of Maryland College Park IRB. Written
informed consent was obtained from all study partici-
pants. No incentive was offered for completion of the
survey.
Survey Instrument
Qualitative interviews conducted among twenty-seven
young Nigerian women who anecdotally reported using
antibiotics to normalize menstrual flow and treat dis-
comfort associated with menstruation [6] informed the
initial content and focus of the survey. A preliminary
version of the survey was then piloted among a focus
group of nine female instructors and students at the
University of Ibadan to evaluate language, content, and
sensitivity of the instrument [27]. Overall, focus group
participants indicated that the survey was “good,”
“straight forward,” and “important.” However, focus
group participants did suggest that a few minor lan-
guage edits should be incorporated into the final survey.
These edits were incorporated and the revised survey
instrument was also visually reformatted to improve
flow and conceptual clarity [28].
The final survey instrument (Additional file 1) con-
sisted of four sections containing both closed and open-
ended questions. The first section included questions
concerning menstrual periods, in particular pain and
other symptoms experienced during menstruation. The
second section consisted of questions relating to analge-
sics and antibiotics that women may have taken before,
during, or after menstruation. The third section con-
tained general demographic questions, and the fourth
section consisted of detailed demographic questions
relating to family status (e.g. single, married, etc.) and
sexual activity. Responses to three questions in the sec-
ond section (Questions 11, 12 and 13 shown in Addi-
tional file 1) were used to calculate the prevalence of
recent antibiotic usage for menstrual symptoms. If a
participant answered “Yes” to question 11 or checked
off any box in questions 12 or 13, they were considered
a “user” of antibiotics for the treatment of menstrual
symptoms. “Self-medication” with antibiotics was veri-
fied using the participants qualitative answers to the
open-ended question at the end of the questionnaire
(Question 22 shown in Additional file 1).
Administration of Survey Instrument
At each university, the surveys were administered by our
Nigerian collaborators, who are instructors, lecturers or
affiliates at the participating universities. All survey
administrators used the same script and study protocol
to invite participants into the study, obtain informed
consent, and administer the surveys.
Statistical Analyses
The survey data were checked, coded, and entered into
a Microsoft Access database. The data were then
cleaned and analyzed using descriptive and inferential
statistics. Simple and multiple logistic regression models
were used to evaluate associations between participant
characteristics and reported usage of antibiotics to treat
menstrual symptoms. All statistical analyses were carried
out using Stata/IC 10 (StataCorp, College Station,
Texas). Continuous data are presented as means, along
with their 95% confidence intervals (CIs).
Results
Study population characteristics
A total of 706 out of 740 administered surveys (95.4%
response rate) were completed and returned by female
students attending Babcock University, Covenant Uni-
versity, University of Ibadan, and Obafemi Awolowo
University. The characteristics of the study population
are summarized in Table 1.
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Menstruation
The majority of study participants (88%: 95% CI, 86% to
91%) reported experiencing three or four menstrual per-
iods during the three-month time period that served as
the focus for this study. Eighty-six percent (95% CI: 83%
to 88%) of participants reported experiencing pain or
discomfort associated with their menstrual periods dur-
ing this time frame. Yet, only 21% (95% CI: 18% to 24%)
of study participants reported ever having seen a doctor
or nurse for pain or discomfort associated with their
menstrual periods. The specific types of pain or discom-
fort that were experienced included cramps; weight gain
and water retention; heavy flow; headaches; pimples or
acne; moodiness; tender or painful breasts; backache,
joint or muscle pain; and other symptoms.
Prevalence of self-medication
When asked about the self-medicated use of analgesics
and other pain-relieving medications, such as aspirin
and ibuprofen, 39% (95% CI: 36% to 43%) of respon-
dents reported that they had used these types of medica-
tions to treat menstrual symptoms in the past three
months. The usage prevalence for these drugs was as
follows: aspirin, 2% (95% CI: 1% to 3%); Panadol (para-
cetamol), 29% (95% CI: 26% to 33%); Panadol Extra
(paracetamol and caffeine), 7% (95% CI: 5% to 9%); ibu-
profen, 9% (95% CI: 7% to 12%); buscopan (butylscopo-
lamine), 10% (95% CI: 8% to 12%); Feldene (piroxicam),
11% (95% CI: 8% to 13%); and other drugs, 11% (95%
CI: 8% to 13%). These other drugs included, but were
not limited to, codeine, Midol, Tylenol and Advil.
Overall, 24% (95% CI: 21% to 27%) of the study popu-
lation reported self-medicating with antibiotics to treat
menstrual symptoms in the past three months. The
mean age when study participants first started taking
antibiotics to treat menstrual symptoms was 15.7 ± 2.96
years. Interestingly, the prevalence of self-medicated
antibiotic use for menstrual symptoms varied depending
on education level (Table 2). In addition, individuals
who were non-science majors were more likely to use
antibiotics for menstrual symptoms compared with lab
science, public health or medicine majors (Table 2, Fig-
ure 1). Study participants who used any pain-relieving
medications (e.g. aspirin, ibuprofen) to treat menstrual
symptoms were more likely to use antibiotics to treat
menstrual symptoms than those who did not use any
pain relievers (Table 2).
In terms of specific symptoms, those study partici-
pants who reported mild to severe heavy flow/heavy
bleeding and mild to severe pimples/acne associated
with menstruation were more likely to use antibiotics to
treat these symptoms compared to individuals who
reported experiencing no heavy flow/heavy bleeding or
pimples/acne (Table 2). Surprisingly, women who
reported mild to severe cramps were less likely to use
antibiotics compared with those who reported experien-
cing no cramps (Table 2). Factors including age, specific
university attended (hence, socio economic status), mar-
ital status, and sexual activity were not significantly
associated with self-medicated use of antibiotics to treat
menstrual symptoms.
Types of antibiotics used
Study participants reported using 12 antibiotics to treat
a variety of symptoms before, during, and after menses.
However, nearly all antibiotic users reported using only
one antibiotic for the treatment of either one or more
Table 1 Study population (n = 706) characteristics
Demographic Characteristics n %
University
Babcock University 237 33.6
Covenant University 167 23.7
University of Ibadan 149 21.1
Obafemi Awolowo University 153 21.7
Education Level
Preliminary level (Pre-college) 3 0.42
Freshman (100 level) 166 23.5
Sophomore (200 level) 194 27.5
Junior (300 level) 171 24.2
Senior (400 level) 73 10.3
Final year of Pharmacy, Law, or Engineering 45 6.4
Final year of Medical School 2 0.3
Masters or Doctorate 26 3.7
Missing data 26 3.7
Area of Concentration
Lab Science, Medicine 285 40.4
Social Sciences 135 19.1
Humanities (Arts, Languages) 97 13.7
Business and Finance 102 14.5
Technology 53 7.5
Missing data 35 5.0
Age
< 17 16 2.3
17-20 330 46.7
21-24 250 35.4
25-29 66 9.4
30-34 16 2.3
35-39 6 0.9
≥ 40 1 0.1
Missing data 21 3.0
Marital Status
Single 609 86.3
Engaged, Married, Separated,
Divorced or Widowed 74 10.5
Missing data 23 3.3
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Table 2 Results of multivariate analysis of factors that may influence self-medication with antibiotics for the treatment
of menstrual symptoms
Independent Variable Odds Ratio 95% Confidence Interval p- value
Cramps
No (n = 187) 1.00 - -
Yes (Mild to severe) (n = 435) 0.57 (0.36 - 0.91) 0.02
Heavy flow/heavy bleeding
No (n = 186) 1.00 - -
Yes (Mild to severe) (n = 436) 1.64 (1.01-2.67) 0.05
Pimples/acne
No (n = 182) 1.00 - -
Yes (Mild to severe) (n = 456) 1.57 (0.98-2.54) 0.06
Education level
Preliminary and undergraduate levels (n = 607) 1.00 - -
Graduate level (n = 73) 0.36 (0.14 - 0.91) 0.03
Major
Lab science, public health or medicine (n = 285) 1.00 - -
Non-science (n = 386) 1.58 (1.03 - 2.50) 0.04
Use of pain relievers to relieve menses symptoms
No (n = 411) 1.00 - -
Yes (n = 276) 3.17 (2.07 - 4.86) <0.001
Age
≤ 20 (n = 346) 1.00 - -
21-29 (n = 316) 1.09 (0.68-1.74) 0.72
≥ 30 (n = 23) 1.78 (0.31-10.1) 0.52
University
Babcock University (n = 237) 1.00 - -
Covenant University (n = 167) 1.13 (0.62-2.07) 0.68
University of Ibadan (n = 149) 1.61 (0.90-2.88) 0.10
Obafemi Awolowo University (n = 153) 1.26 (0.69-2.28) 0.45
Figure 1 Prevalence of self-medication with antibiotics for the treatment of menstrual symptoms among University women in
Southwest Nigeria by major area of study and symptoms.
Sapkota et al. BMC Public Health 2010, 10:610
http://www.biomedcentral.com/1471-2458/10/610
Page 5 of 10
specific symptoms during the 3-month period that
served as the focus for the survey. Table 3 summarizes
the types of antibiotics that were used to treat specific
menstrual symptoms and provides estimates of the pre-
valence of use for each antibiotic. Ampicillin, tetracy-
cline, ciprofloxacin and metronidazole were used to
treat the most menstrual symptoms (≥ 7 symptoms). If
a preferred antibiotic was not available, 8% (95% CI: 6%
to 10%) of study participants reported that they would
use another type of antibiotic to treat the specific men-
strual symptom. When asked whether these antibiotics
were effective in relieving symptoms, a number of parti-
cipants reported that the drugs relieved each of the
symptoms, of which the largest proportions indicated
that antibiotics relieved backache, joint or muscle pain
(10%, 95% CI: 8% to 12%), headaches (10%, 95% CI: 8%
to 12%), and cramps (9%, 95% CI: 6% to 11%).
Sources of information and antibiotics
Study participants also reported that a variety of indivi-
duals first recommended that they take antibiotics to
treat menstrual symptoms. Doctors or nurses (6%, 95%
CI: 4% to 7%), friends (6%, 95% CI: 4% to 7%) and
family members (7%, 95% CI: 5% to 8%) were the indivi-
duals who were most often cited as recommending anti-
biotics for these symptoms (Figure 2). However, the
Table 3 Number of study participants using specific antibiotics to treat specific menstrual symptoms (n, (%, 95%
confidence interval)), and estimates of the overall prevalence of use for each antibiotic for one or more menstrual
symptoms (%, 95% confidence interval)
Symptoms
Antibiotic Cramps Weight
gain,
bloating
Heavy
flow,
heavy
bleeding
Headaches Pimples,
acne
Aggression,
moodiness
Tender,
painful
breasts
Backache,
joint or
muscle pain
Other Prevalence of use
for ≥ 1 menstrual
symptom
Ampicillin 4 (0.6,
0.01-
1.1)
5 (0.7,
0.08-1.3)
6 (0.9, 0.1-
1.5)
2 (0.3, 0.1-
0.6)
2 (0.3, 0.1-
0.6)
0 1 (0.14,
-0.01-0.4)
2 (0.3, 0.1-
0.6)
3 (0.4,
0.05-
0.9)
2.6 (1.4-3.7)
Ampiclox
(Ampicillin +
Cloxacillin)
2 (0.3,
0.1-0.6)
0 6 (0.9, 0.1-
1.5)
1 (0.14,
-0.01-0.4)
2 (0.3, 0.1-
0.6)
0 0 0 1
(0.14,
-0.01-
0.4)
2.0 (0.95-3.0)
Pefloxacin 1 (0.14,
-0.01-
0.4)
3 (0.4,
0.05-0.9)
1 (0.14,
-0.01-0.4)
0 0 0 0 1 (0.14, -0.01-
0.4)
0 0.9 (0.2-1.5)
Amoxicillin 2 (0.3,
0.1-0.6)
1 (0.14,
-0.01-0.4)
3 (0.4, 0.05-
0.9)
3 (0.4, 0.05-
0.9)
0 0 0 0 0 1.3 (0.4-2.1)
Augmentin 1 (0.14,
-0.01-
0.4)
1 (0.14,
-0.01-0.4)
2 (0.3, 0.1-
0.6)
0 0 0 0 0 1
(0.14,
-0.01-
0.4)
0.7 (0.1-1.3)
Ofloxacin 2 (0.3,
0.1-0.6)
1 (0.14,
-0.01-0.4)
2 (0.3, 0.1-
0.6)
2 (0.3, 0.1-
0.6)
0 0 0 0 0 1.1 (0.4-1.9)
Tetracycline 6 (0.9,
0.1-1.5)
1 (0.14,
-0.01-0.4)
4 (0.6, 0.01-
1.1)
1 (0.14,
-0.01-0.4)
0 0 1 (0.14,
-0.01-0.4)
2 (0.3, 0.1-
0.6)
7 (1.0,
0.2-
1.7)
2.7 (1.5-3.9)
Ciprofloxacin 2 (0.3,
0.1-0.6)
1 (0.14,
-0.01-0.4)
1 (0.14,
-0.01-0.4)
2 (0.3, 0.1-
0.6)
1 (0.14,
-0.01-0.4)
0 0 1 (0.14, -0.01-
0.4)
4 (0.6,
0.01-
1.1)
1.4 (0.5-2.3)
Metronidazole 6 (0.9,
0.1-1.5)
1 (0.14,
-0.01-0.4)
2 (0.3, 0.1-
0.6)
1 (0.14,
-0.01-0.4)
0 1 (0.14, -0.01-
0.4)
1 (0.14,
-0.01-0.4)
1 (0.14, -0.01-
0.4)
1
(0.14,
-0.01-
0.4)
3.0 (1.7-4.2)
Cotrimoxazole 3 (0.4,
0.05-
0.9)
0 0 3 (0.4, 0.05-
0.9)
1 (0.14,
-0.01-0.4)
0 1 (0.14,
-0.01-0.4)
1 (0.14, -0.01-
0.4)
2 (0.3,
0.1-
0.6)
1.6 (0.6-2.5)
Streptomycin 1 (0.14,
-0.01-
0.4)
0 2 (0.3, 0.1-
0.6)
1 (0.14,
-0.01-0.4)
0 0 0 0 0 0.6 (0.01-1.1)
Gentamicin 3 (0.4,
0.05-
0.9)
1 (0.14,
-0.01-0.4)
0 2 (0.3, 0.1-
0.6)
1 (0.14,
-0.01-0.4)
0 0 0 0 1.0 (0.3-1.7)
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antibiotics used to treat menstrual symptoms were most
often obtained from local chemists or pharmacists
(10.2%, 95% CI: 8% to 12%) (Figure 2).
Discussion
In this study, we identified that approximately 1 out of 4
surveyed female university students in Southwest
Nigeria practiced self-medication with antibiotics to
treat a variety of menstrual symptoms. Ampicillin, tetra-
cycline, ciprofloxacin and metronidazole were used to
treat the most menstrual symptoms, and the drugs were
most often obtained from local chemists or pharmacists.
To our knowledge, this is the first formal study to
report such a high rate of antibiotic self-medication
among women of child-bearing age in Southwest
Nigeria.
These results are potentially more alarming compared
with other unorthodox, self-medicated uses of antibio-
tics because the menstrual cycle occurs monthly. While
we did not collect data concerning the frequency of self-
medication with antibiotics for the treatment of men-
strual symptoms, we speculate that the use of antibiotics
for menstrual symptoms that may last only a few days
every month could possibly provide frequent, low-dose
exposures among users. Low doses of antibiotics on a
regular basis may expose the normal gut bacterial flora–
which can cause UTIs–to sub-inhibitory doses that
favor the selection of resistant bacteria. A previous
study in Southwest Nigeria identified a high prevalence
of UTIs among women of child-bearing age [29], and
other studies have shown that the prevalence of multiple
resistance to commonly-used antibiotics among UTI
bacterial isolates from Southwest Nigeria is considerably
higher than that of any other part of the world
[3,30-32]. Thus, it is possible that the self-medication
behaviors that we have identified among young women
in this study may be contributing to the elevated rates
of antibiotic-resistant UTIs that have been documented
in this region.
However, additional studies are necessary to identify
whether the antibiotic self-medication practices
described here are also prevalent among Nigerian
women who do not attend college. The young women
surveyed in this study represent a small, elite proportion
of the female, Nigerian population [21]. Thus, it is
unclear whether the responses of the surveyed women
are representative of other women in Southwest Nigeria
(and beyond) who do not attend college. Similarly, at
this time, it is difficult to estimate 1) the overall magni-
tude of the antibiotic selective pressures; and 2) the spe-
cific subsequent effects on bacterial antibiotic resistance
that are associated with self-medicated antibiotic usage
for the treatment of menstrual symptoms in Nigeria.
While the present study was the first formal study to
assess self-medication with antibiotics for menstrual
symptoms among university women in Southwest
Nigeria, another recent study identified antibiotic use
for menstrual symptoms among secondary school girls
in Osun State (the location of one of our participating
universities) [33]. In this study, Ogunfowokan and
Figure 2 Individuals who recommended the use of antibiotics to treat menstrual symptoms and individuals or entities who provided
antibiotics to study participants.
Sapkota et al. BMC Public Health 2010, 10:610
http://www.biomedcentral.com/1471-2458/10/610
Page 7 of 10
Babatunde (2010) described that 1% of secondary school
girls reported using tetracycline for the management of
menstrual pain [33]. This is similar to our finding that
2.7% of our study participants specifically used tetracy-
cline to treat several menstrual symptoms including
cramps, and heavy flow (Table 3). However, since Ogun-
fowokan and Babatunde (2010) used a survey with open-
ended questions on the self-management of menstrual
symptoms and tetracycline was noted as the only cited
antibiotic, the overall prevalence of antibiotic use for the
treatment of menstrual symptoms is likely lower in the
Ogunfowokan and Babatunde (2010) study compared to
the present study.
Beyond self-medicated use of antibiotics for menstrual
symptoms, other studies have evaluated antibiotic self-
medication patterns, in general, among other popula-
tions in Nigeria indicating that this overall practice is
common. For example, Afolabi et al. (2010) recently
identified that 30.4% of surveyed dental patients in
Ondo State– which is also located in Southwest
Nigeria–practiced self-medication with antibiotics [34].
In another recent study, Afolabi (2008) assessed factors
that are associated with self-medication, in general,
among market women (mostly of the Yoruba ethnic
group) in Lagos State, located in Southwest Nigeria [18].
In this study, level of education was identified as a
major factor that influenced self-medication patterns,
while age was not significantly associated with self-medi-
cation [18]. These data are similar to our findings that
show that higher levels of education are inversely asso-
ciated with self-medicated antibiotic use for menstrual
symptoms (Table 2), while age and socio-economic sta-
tus are not significantly associated with this type of anti-
biotic usage. In contrast, Afolabi (2008) identified that
market women most often obtained their information
about medications, as well as the medications them-
selves, from patent medicine stores, while the present
study found that information about antibiotic usage and
the antibiotics themselves were most often obtained
from family members and local chemists or pharmacists,
respectively. Previous studies conducted in Africa have
also identified pharmacies as important sources of self-
administered drugs [17,35].
Understanding the sources of information and sources
of drugs for antibiotic self-medication can help in the
formulation of community-based interventions that can
help to reduce self-medication practices. Our data sug-
gest that interventions are indicated at several levels:
public health education directed at populations, and
medical education directed at health professionals. Since
girls are more likely to receive information about men-
struation and other health issues from their mothers,
other female relatives and friends rather than through
formal education sources [36,37], providing health
education on the appropriate use of antibiotics to female
family members in the general population may be more
productive initially than educating university or school
girls directly.
Medical education efforts also are indicated since our
findings show that clinicians are likely to recommend
and pharmacists are likely to provide antimicrobials for
menstrual problems. These efforts could be directed at
medical and other health profession students who are at
the initial stages of their medical education, as well as
practicing physicians, and other healthcare professionals.
Encouragingly, we found that students who studied
medicine and public health were less likely to misuse
antibiotics for menstrual complaints compared to non-
science majors. This suggests that those women who are
currently studying disciplines related to healthcare fields
could positively impact the individuals whom they treat
in the future with regard to potential reductions in self-
medication practices [15].
This is a cross-sectional study that utilized a self-
administered survey to estimate the prevalence of self-
medicated antibiotic use in the past. Therefore, by
design, recall bias cannot be ruled out. In addition, since
the survey was self-administered, respondents may have
skipped questions that they did not understand. More-
over, respondents may have underreported antibiotic
usage because issues related with menses are culturally
sensitive and often viewed as a taboo subject. Respon-
dents also might not have known what an antibiotic is;
although this may be less of an issue particularly among
our survey respondents since they were all university
students. The fact that surveys were administered in
residence halls or lecture halls depending on the univer-
sity is also a limitation. However, the data show that
survey administration in either residence halls or lecture
halls was not a factor that influenced the findings.
Another limitation of the study is that, while random
sampling was completed at each university, the universi-
ties themselves were selected by convenience. In a study
of this type, we did not have the ability to randomly
select a sample of all Nigerian universities for inclusion
in the study because we did not have the luxury of hav-
ing collaborators present at every Nigerian university
who could complete the necessary field work. As a
result, it is unclear whether our findings are generaliz-
able to other Nigerian universities.
Conclusions
In summation, our findings provide the first prevalence
data on self-medication with antibiotics for the treat-
ment of menstrual symptoms among young Nigerian
university women. We speculate that this type of prac-
tice could provide monthly, low-dose exposures to anti-
biotics among users, and could partially explain the high
Sapkota et al. BMC Public Health 2010, 10:610
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rates of antibiotic-resistant UTIs previously described in
Nigeria.
By targeting educated women of child-bearing age, this
study addresses a population with more resources than
the general population. Future research should be
expanded to include other populations of Nigerian women
to determine the overall prevalence of self-medicated anti-
biotic use for menstrual symptoms in the country, as well
as any additional knowledge deficits and attitudinal bar-
riers to eliminating antimicrobial misuse. Such informa-
tion could then be used to develop education initiatives
and theory-based behavior modification programs directed
at reducing the misuse of antibiotics among women and
their healthcare providers in Nigeria.
Additional material
Additional file 1: Women’s Health and Health Behaviors Survey. The
survey instrument used in the study entitled, “Self-medication with
antibiotics for the treatment of menstrual symptoms in southwest
Nigeria: a cross-sectional study.”
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